FIELD NOvel Markers in Diabetes (NOMAD)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1147897

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The FIELD trial, one of the largest type 2 diabetes studies world-wide, involving 9795 people over five years, demonstrated that the blood fat lowering drug fenofibrate protects against diabetic eye, kidney and nerve damage and some cardiovascular events. The FIELD NOMAD Study will identify novel molecular and biochemical markers of diabetes complications and treatment response in at least 1000 subjects with diabetes. Results are expected to improve diabetes care and develop new treatments.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2020

Funding Scheme: Project Grants

Funding Amount: $725,536.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | gene expression | pharmacology | proteomics | vascular disease

Related Links